Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies
Nur Zawanah Zabidi, Hern Liang Liew, Isra Ahmad Farouk, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 944-944
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Psoralidin acts as a dual protease inhibitor against PLpro and Mpro of SARS‐CoV‐2
Aditya Trivedi, Tushar Kushwaha, Areef Ishani, et al.
FEBS Journal (2025)
Closed Access
Origin, evolution, and spread of SARS-CoV-2
Jonas Michel Wolf, Lucas Wolf, Paul C. Wolf, et al.
Elsevier eBooks (2025), pp. 5-19
Closed Access
Unravelling the Potential of Anticancer Drugs for SARS-CoV-2
Zheng Yao Low, Ka Heng Wong, Ashley Jia Wen Yip, et al.
Current Pharmacology Reports (2025) Vol. 11, Iss. 1
Open Access
Improving soluble recombinant SARS-CoV-2 papain-like protease production in Escherichia coli through chaperonin and maltose-binding protein tag: purification and kinetic characterization
Riswanto Napitupulu, Maimunah, Amarila Malik, et al.
Preparative Biochemistry & Biotechnology (2025), pp. 1-10
Closed Access
Assessing the Burden and Cost of COVID-19 Across Variants in Commercially Insured Immunocompromised Populations in the United States: Updated Results and Trends from the Ongoing EPOCH-US Study
Amita Ketkar, Vincent J. Willey, Lisa Glasser, et al.
Advances in Therapy (2024) Vol. 41, Iss. 3, pp. 1075-1102
Open Access | Times Cited: 5
Effectiveness of Oral Nirmatrelvir/Ritonavir vs. Intravenous Three-Day Remdesivir in Preventing Progression to Severe COVID-19: A Single-Center, Prospective, Comparative, Real-Life Study
Dimitrios Basoulis, Aristeidis Tsakanikas, Aikaterini Gkoufa, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1515-1515
Open Access | Times Cited: 10
Development and Validation of a High-Performance Liquid Chromatography with Tandem Mass Spectrometry (HPLC-MS/MS) Method for Quantification of Major Molnupiravir Metabolite (β-D-N4-hydroxycytidine) in Human Plasma
Timofey Komarov, P. K. Karnakova, O. A. Archakova, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2356-2356
Open Access | Times Cited: 8
High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1
William Bolland, Vincent Michel, Delphine Planas, et al.
Journal of Virology (2023) Vol. 98, Iss. 1
Open Access | Times Cited: 8
Divergent pathogenetic outcomes in BALB/c mice following Omicron subvariant infection
John M. Powers, Sarah R. Leist, Michael L. Mallory, et al.
Virus Research (2024) Vol. 341, pp. 199319-199319
Open Access | Times Cited: 2
The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the attenuated phenotype of Omicron virus in a feline model of infection
Mathias Martins, Mohammed Nooruzzaman, Jessie Lee Cunningham, et al.
Journal of Virology (2024) Vol. 98, Iss. 3
Open Access | Times Cited: 2
14‐3‐3 Family of Proteins: Biological Implications, Molecular Interactions, and Potential Intervention in Cancer, Virus and Neurodegeneration Disorders
Zheng Yao Low, Ashley Jia Wen Yip, Alvin Man Lung Chan, et al.
Journal of Cellular Biochemistry (2024) Vol. 125, Iss. 7
Open Access | Times Cited: 2
The small molecule inhibitor of SARS-CoV-2 3CLpro EDP-235 prevents viral replication and transmission in vivo
Michael H. J. Rhodin, Archie C. Reyes, Anand Balakrishnan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
An Advax-CpG55.2™ adjuvanted recombinant spike protein vaccine protects cynomolgus macaques from a homologous SARS-CoV-2 virus challenge
Yoshikazu Honda‐Okubo, Lei Li, Greiciely O. André, et al.
Vaccine (2023) Vol. 41, Iss. 32, pp. 4710-4718
Open Access | Times Cited: 7
Advax-CpG55.2-adjuvanted monovalent or trivalent SARS-CoV-2 recombinant spike protein vaccine protects hamsters against heterologous infection with Beta or Delta variants
Yoshikazu Honda‐Okubo, Richard A. Bowen, Mckinzee Barker, et al.
Vaccine (2023) Vol. 41, Iss. 48, pp. 7116-7128
Closed Access | Times Cited: 7
The Effect of Select SARS-CoV-2 N-Linked Glycan and Variant of Concern Spike Protein Mutations on C-Type Lectin-Receptor-Mediated Infection
Arjan Bains, Wenyan Guan, Patricia J. LiWang
Viruses (2023) Vol. 15, Iss. 9, pp. 1901-1901
Open Access | Times Cited: 5
B<sub>5</sub>N<sub>10</sub> Nanocarrier Functionalized with Al, C, Si Atoms: A Drug Delivery Method for Infectious Disease Remedy
Fatemeh Mollaamin, Majid Monajjemi
OBM Genetics (2024) Vol. 08, Iss. 01, pp. 1-19
Open Access | Times Cited: 1
Genetic diversity and genomic epidemiology of SARS-CoV-2 during the first three years of the pandemic in Morocco: Comprehensive sequence analysis, including the unique lineage B.1.528 in Morocco
Soulandi Djorwé, Abderrahim Malki, Néhémie Nzoyikorera, et al.
(2024)
Open Access | Times Cited: 1
Combating Emerging Respiratory Viruses: Lessons and Future Antiviral Strategies
Palaniyandi Muthukutty, Jaime MacDonald, So Young Yoo
Vaccines (2024) Vol. 12, Iss. 11, pp. 1220-1220
Open Access | Times Cited: 1
The effectiveness of novel oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during predominance of omicron XBB subvariants
Chi‐Kuei Hsu, Wan‐Hsuan Hsu, Bo-Wen Shiau, et al.
Expert Review of Anti-infective Therapy (2024), pp. 1-8
Closed Access | Times Cited: 1
Mutation Trajectory of Omicron SARS-CoV-2 Virus, Measured by Principal Component Analysis
Tomokazu Konishi, Toa Takahashi
COVID (2024) Vol. 4, Iss. 4, pp. 571-581
Open Access | Times Cited: 1
Wastewater Surveillance of SARS-CoV-2 in Zambia: An Early Warning Tool
Doreen Mainza Shempela, Walter Muleya, Steward Mudenda, et al.
(2024)
Open Access | Times Cited: 1
A highly sensitive on-site duplex genotyping method dRPG for simultaneous detection of SARS-CoV‑2 key mutations with single nucleotide resolution
Chenjie Zhao, Yixin Tang, Miao Xu, et al.
Sensors and Actuators B Chemical (2024) Vol. 418, pp. 136238-136238
Closed Access | Times Cited: 1
Subacute thyroiditis after receiving the COVID-19 vaccine
Yingshuo Zhong, Di Chang, Xiaohui Yang, et al.
Respiratory Medicine Case Reports (2024) Vol. 51, pp. 102096-102096
Open Access | Times Cited: 1
Impact of Vaccination Status on COVID-19 Severity and Pulmonary Involvement
Sorina Maria Denisa Laitin, Luminiţa Bădiţoiu, Ruxandra Laza, et al.
Medicina (2024) Vol. 60, Iss. 12, pp. 1919-1919
Open Access | Times Cited: 1
Vaccine Strategies Against RNA Viruses: Current Advances and Future Directions
Kuei-Ching Hsiung, Huan-Jung Chiang, Sebastian Reinig, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1345-1345
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top